Seite - (000404) - in Biomedical Chemistry: Current Trends and Developments

Krishnan, S. R., George, S. K. Nanotherapeutics in cancer prevention, diagnosis and treatment. In Pharmacology and Therapeutics, (Ed. Thatha S. J.). Gowder, ISBN 978-953-51-1620-2, (2014), DOI: 10.5772/58419. Kuppusamy, P., Li, H., Ilangovan, G., et al. (2002). Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. Cancer Research, 62(1), 307-312. Lammers, T., Kiessling, F., Hennink, W. E., et al. (2012). Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress. Journal of Controlled Release, 161(2), 175-187. Landry, R., Jacobs, P. M., Davis, R., et al. (2005). Pharmacokinetic study of ferumoxytol: A new iron replacement therapy in normal subjects and hemodialysis patients. American Journal of Nephrology, 25(4), 400-410. Le Garff-Tavernier, M., Herbi, L., de Romeuf, C., et al. (2014). Antibody-dependent cellular cytotoxicity of the optimized anti-cd20 monoclonal antibody ublituximab on chronic lymphocytic leukemia cells with the 17p deletion. Leukemia, 28(1), 230-233. Lee, C. H., Cheng, S. H., Huang, I. P., et al. (2010). Intracellular ph-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. Angewandte Chemie International Edition, 49(44), 8214-8219. Lee, G. Y., Qian, W. P., Wang, L., et al. (2013a). Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and mri of pancreatic cancer. ACS Nano, 7(3), 2078- 2089. Lee, J. H., Chen, K. J., Noh, S. H., et al. (2013b). On-demand drug release system for in vivo cancer treatment through self-assembled magnetic nanoparticles. Angewandte Chemie International Edition, 52(16), 4384-4388. Lee, S., Margolin, K. (2011). Cytokines in cancer immunotherapy. Cancers (Basel), 3(4), 3856- 3893. Lesterhuis, W. J., de Vries, I. J., Adema, G. J., et al. (2004). Dendritic cell-based vaccines in cancer immunotherapy: An update on clinical and immunological results. Annals of Oncology, 15(S4), iv145-151. Liao, L., Liu, J., Dreaden, E. C., et al. (2014). A convergent synthetic platform for single- nanoparticle combination cancer therapy: Ratiometric loading and controlled release of cisplatin, doxorubicin, and camptothecin. Journal of the American Chemical Society, 136(16), 5896-5899. Ling, D., Park, W., Park, S. J., et al. (2014). Multifunctional tumor ph-sensitive self-assembled nanoparticles for bimodal imaging and treatment of resistant heterogeneous tumors. Journal of the American Chemical Society, 136(15), 5647-5655. Liu, C., Noorchashm, H., Sutter, J. A., et al. (2007). B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates. Nature Medicine, 13(11), 1295-1298. Liu, D., Bimbo, L. M., Mäkilä, E., et al. (2013a). Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles. Journal of Controlled Release, 170(2), 268-278. Liu, D., Mäkilä, E., Zhang, H., et al. (2013b). Nanostructured porous silicon-solid lipid nanocomposite: Towards enhanced cytocompatibility and stability, reduced cellular association, and prolonged drug release. Advanced Functional Materials, 23(15), 1893-1902. Liu, D. F., Zhang, H. B., Mäkilä, E., et al. (2015). Microfluidic assisted one-step fabrication of